The rapid spread properties of the coronavirus have made the Covid-19 Rapid Cassette tests an urgent need in diagnosing the disease. Antibody tests, first of all, show whether you previously had the virus. The reason for the high level of interest in these tests in the United States and European countries is that it may be possible to issue special Immune Passports to return to job for those who had the disease.

The quarantine measures have had serious impacts on both the global and national economies. All countries will have to loosen the measures at some point so that citizens can recover economically. In this sense, it will be important to see if people who will go out, get involved in social life and go to work previously had the disease. Thanks to antibody tests, you can find out whether you had the disease and your body already produced the necessary antibodies, even if you had the disease but did not experience any symptoms. This would ensure that you will be given an immune passport or certificate.

In addition to being a tool for screening the population and ensuring the isolation of infected people, antibody tests are also important in finding out if the body has produced antibodies. The Cellex qSARS-CoV-2 IgG/IgM Cassette-Type Rapid Test has been developed to fulfil all the requirements for the diagnosis of SARS-CoV-2 (Covid-19) infection with quick, easy-to-understand and qualitative results.

Besides, the biggest achievement of South Korea, which is shown as the best country in preventing the spread of the coronavirus disease, has been its ability to apply diagnostic tests to a very large population. In this way, they have been able to see the number of infected people and implement successful isolation and treatment measures accordingly. By the middle of March 2020, South Korea had already carried out 300,000 diagnostic tests. Testing is the most important measure in early diagnosis of the disease. Early diagnosis prevents the spread of the disease. The antibody tests also identify healthy people who previously had the disease and ensure that their blood is given to those struggling with the disease (Plasma Therapy).

Thanks to the antibody tests, we have the opportunity to have access to the following information:
- Whether we previously had the disease or not
- Whether we are immune to disease or not
- Who can become plasma donors for patients in poor medical condition
- Who can comfortably go to work and get involved in social life
- When the social life may return to normal (when serological tests reveal a herd immunity rate around 60%, restrictions may be lifted.)